Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Med Decis Making. 2022 Jun 30;43(1):3–20. doi: 10.1177/0272989X221103163

Table 5:

Cost-effectiveness analysis results for the Sick-Sicker model. ND: Non-dominated strategy; D: Dominated strategy.

Strategy Costs ($) QALYs Incremental Costs ($) Incremental QALYs ICER ($/QALY) Status
Standard of care 151,580 20.711 NA NA NA ND
Strategy B 259,100 22.184 107,521 1.473 72,988 ND
Strategy AB 378,875 23.137 119,775 0.952 125,764 ND
Strategy A 284,805 21.499 NA NA NA D